RYAH Signs Partnership Agreement With SOS Cannabis for Reimbursement for Canadian Patients

RYAH Signs Partnership Agreement With SOS Cannabis for Reimbursement for Canadian Patients

NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- RYAH Medtech Inc. (“RYAH” or the “Company”), announced today it has executed a partnership agreement with SOS cannabis (“SOS Cannabis”). The agreement will provide Canadian patients with the ability to obtain free legal representation to seek reimbursement from different government agencies for the medical costs associated with purchasing the RYAH dose-measuring vaporizer and proprietary dry-herb cartridges.

The Best Medical Cannabis Licensed Producers

The Best Medical Cannabis Licensed Producers

Over the last year we’ve seen a surge in Licensed Medical Cannabis producers. With the legalization of recreational use many great licensed producers have come out of the shadows and are now taking part in the booming industry. There are many licensed producers out there that we could talk about. To find one that fits with you and your needs, research is required.

The Medical Cannabis Industry : Behind the Scenes

The Medical Cannabis Industry : Behind the Scenes

The Medical Cannabis Industry is a multi-million dollar industry. Medical Cannabis has been used as a treatment for various illnesses and conditions for a number of years now. With the the recent legalization of the product for recreational purposes, previously unknown corporations have become known through either public trading on the Toronto Stock Exchange or popular knowledge.

New Regulations in the Cannabis Industry

New Regulations in the Cannabis Industry

With the legalization of recreational cannabis, the Canadian Government has implemented new regulations to control the use and distribution of both medical and recreational cannabis. A new form of regulation that came with the advent of last year’s legalization were the regulations on driving while under the influence of Cannabis.

Relevium signs exclusive agreement with SOS Cannabis for reimbursement for Pediatric Patients

Relevium signs exclusive agreement with SOS Cannabis for reimbursement for Pediatric Patients

July 10, 2019 - MONTREAL, QUEBEC – Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has executed an exclusivity agreement to partner with SOS Cannabis to provide pediatric customers the ability to obtain free legal representation to seek reimbursement for the costs of medical cannabinoid therapy from different government agencies for the treatment of medical conditions for Pediatric Patients